Skip to main content

Table 1 Population characteristics

From: Microbiologically confirmed infections and antibiotic-resistance in a national surveillance study of hospitalised patients who died with COVID-19, Italy 2020–2021

Number of patients evaluated

157

Age (median, interquartile range)

71 (63–79)

 

N

%

Sex

Male

117

74.5

Female

40

25.5

Patient location before admission

Home

123

78.3

Other hospital

18

11.5

Long-term care facility

11

7.0

Other

5

3.2

Geographical area (Italy)

North

111

70.7

Center

27

17.2

South

19

12.1

Period of hospitalisation

February 2020-September 2020

72

45.9

October 2020-April 2021

85

54.1

Comorbidities

Chronic respiratory disease

32

20.4

Neoplastic disease

19

12.1

Diabetes

42

26.8

Chronic renal failure

26

16.6

Antibiotics in the first 48 h from admission

Any

95

60.5

Azithromycin

40

25.5

Ceftriaxone

43

27.4

Piperacillin-tazobactam

22

14.0

Others

26

16.6

Steroids in the first 48 h from admission

72

45.9

Admission to Intensive Care Unit (ICU)

111

70.7

Level of care at first positive blood culture

ICU

51

60.7

Other wards

33

39.3

Level of care at first positive lower respiratory tract culture

ICU

95

88.8

Other wards

12

11.2

Level of care at first positive urinary antigen test (for S. pnemoniae or L. pneumophila)

ICU

3

18.8

Other wards

13

81.2

Sepsis reported as a cause of death in the death certificate

57

36.3